news $2.6 million granted to create pan-coronavirus vaccine 25 October 2021 | By Anna Begley (Drug Target Review) The La Jolla Institute for Immunology and Brigham and Women's Hospital will collaborate to develop a pan-coronavirus vaccine.
news T-cell exhaustion may limit long-term immunity in COVID-19 patients 22 January 2021 | By Hannah Balfour (Drug Target Review) Researchers suggest patients who develop mild COVID-19 may not be able to fight reinfection very effectively because their CD8+ T cells show signs of exhaustion.
news Researchers emphasise importance of antigen valency for vaccine efficacy 28 August 2020 | By Victoria Rees (Drug Target Review) Researchers have shown that factoring in valency to vaccine design can improve the number of antibody binding sites on an antigen.
news Researchers halt type 1 diabetes onset by denervating the pancreas 27 August 2020 | By Hannah Balfour (Drug Target Review) Scientists denervated the pancreas using surgery or pharmacological agents to protect it from immune-mediated beta cell destruction, preventing the onset of type 1 diabetes.
news Potential target to control T follicular helper cells identified 23 June 2020 | By Victoria Rees (Drug Target Review) A new study shows how the Bcl6 protein can regulate T follicular helper cells, presenting a target for autoimmune and infectious diseases.